124 related articles for article (PubMed ID: 2359014)
1. Effects of zacopride and BMY25801 (batanopride) on radiation-induced emesis and locomotor behavior in the ferret.
King GL; Landauer MR
J Pharmacol Exp Ther; 1990 Jun; 253(3):1026-33. PubMed ID: 2359014
[TBL] [Abstract][Full Text] [Related]
2. Emesis and defecations induced by the 5-hydroxytryptamine (5-HT3) receptor antagonist zacopride in the ferret.
King GL
J Pharmacol Exp Ther; 1990 Jun; 253(3):1034-41. PubMed ID: 2162943
[TBL] [Abstract][Full Text] [Related]
3. Prevention and treatment of the gastric symptoms of radiation sickness.
Dubois A; Fiala N; Boward CA; Bogo V
Radiat Res; 1988 Sep; 115(3):595-604. PubMed ID: 3174940
[TBL] [Abstract][Full Text] [Related]
4. The antiemetic profile of zacopride.
Smith WL; Alphin RS; Jackson CB; Sancilio LF
J Pharm Pharmacol; 1989 Feb; 41(2):101-5. PubMed ID: 2568416
[TBL] [Abstract][Full Text] [Related]
5. Studies on the emetic and antiemetic properties of zacopride and its enantiomers.
Sancilio LF; Pinkus LM; Jackson CB; Munson HR
Eur J Pharmacol; 1991 Jan; 192(3):365-9. PubMed ID: 2055236
[TBL] [Abstract][Full Text] [Related]
6. Emetic activity of zacopride in ferrets and its antagonism by pharmacological agents.
Sancilio LF; Pinkus LM; Jackson CB; Munson HR
Eur J Pharmacol; 1990 Jun; 181(3):303-6. PubMed ID: 2384137
[TBL] [Abstract][Full Text] [Related]
7. The emetic activity of centrally administered cisplatin in cats and its antagonism by zacopride.
Smith WL; Callaham EM; Alphin RS
J Pharm Pharmacol; 1988 Feb; 40(2):142-3. PubMed ID: 2897451
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effect of zacopride on Cisplatin-induced delayed emesis in ferrets.
Yamakuni H; Nakayama H; Matsui S; Imazumi K; Matsuo M; Mutoh S
J Pharmacol Sci; 2006 May; 101(1):99-102. PubMed ID: 16651699
[TBL] [Abstract][Full Text] [Related]
9. Preliminary evidence for the involvement of the putative 5-HT4 receptor in zacopride- and copper sulphate-induced vomiting in the ferret.
Bhandari P; Andrews PL
Eur J Pharmacol; 1991 Nov; 204(3):273-80. PubMed ID: 1663456
[TBL] [Abstract][Full Text] [Related]
10. 5-HT3 receptor agonism may be responsible for the emetic effects of zacopride in the ferret.
Middlefell VC; Price TL
Br J Pharmacol; 1991 May; 103(1):1011-2. PubMed ID: 1831684
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the 5-HT3 receptor antagonist properties of ICS 205-930, GR38032F and zacopride.
Cohen ML; Bloomquist W; Gidda JS; Lacefield W
J Pharmacol Exp Ther; 1989 Jan; 248(1):197-201. PubMed ID: 2521513
[TBL] [Abstract][Full Text] [Related]
12. RG 12915: a potent 5-hydroxytryptamine-3 antagonist that is an orally effective inhibitor of cytotoxic drug-induced emesis in the ferret and dog.
Fitzpatrick LR; Lambert RM; Pendley CE; Martin GE; Bostwick JS; Gessner GW; Airey JE; Youssefyeh RD; Pendleton RG; Decktor DL
J Pharmacol Exp Ther; 1990 Aug; 254(2):450-5. PubMed ID: 2166791
[TBL] [Abstract][Full Text] [Related]
13. The role of the abdominal visceral innervation and 5-hydroxytryptamine M-receptors in vomiting induced by the cytotoxic drugs cyclophosphamide and cis-platin in the ferret.
Hawthorn J; Ostler KJ; Andrews PL
Q J Exp Physiol; 1988 Jan; 73(1):7-21. PubMed ID: 3347698
[TBL] [Abstract][Full Text] [Related]
14. The effects of orally administered Y-25130, a selective serotonin3-receptor antagonist, on chemotherapeutic agent-induced emesis.
Haga K; Inaba K; Shoji H; Morimoto Y; Fukuda T; Setoguchi M
Jpn J Pharmacol; 1993 Nov; 63(3):377-83. PubMed ID: 8107329
[TBL] [Abstract][Full Text] [Related]
15. Development of high-affinity 5-HT3 receptor antagonists. 2. Two novel tricyclic benzamides.
Youssefyeh RD; Campbell HF; Airey JE; Klein S; Schnapper M; Powers M; Woodward R; Rodriguez W; Golec S; Studt W
J Med Chem; 1992 Mar; 35(5):903-11. PubMed ID: 1548679
[TBL] [Abstract][Full Text] [Related]
16. Anxiolytic-like activity of R(+)- and S(-)-zacopride in mice.
Young R; Johnson DN
Eur J Pharmacol; 1991 Aug; 201(2-3):151-5. PubMed ID: 1686755
[TBL] [Abstract][Full Text] [Related]
17. The antiemetic profile of Y-25130, a new selective 5-HT3 receptor antagonist.
Fukuda T; Setoguchi M; Inaba K; Shoji H; Tahara T
Eur J Pharmacol; 1991 Apr; 196(3):299-305. PubMed ID: 1654255
[TBL] [Abstract][Full Text] [Related]
18. Evidence for an extra-abdominal site of action for the 5-HT3 receptor antagonist BRL24924 in the inhibition of radiation-evoked emesis in the ferret.
Andrews PL; Hawthorn J
Neuropharmacology; 1987 Sep; 26(9):1367-70. PubMed ID: 3670559
[TBL] [Abstract][Full Text] [Related]
19. 5-HT3 receptor antagonists ameliorate emesis in the ferret evoked by neutron or proton radiation.
King GL; Rabin BM; Weatherspoon JK
Aviat Space Environ Med; 1999 May; 70(5):485-92. PubMed ID: 10332945
[TBL] [Abstract][Full Text] [Related]
20. Zacopride, a potent 5-HT3 antagonist.
Smith WW; Sancilio LF; Owera-Atepo JB; Naylor RJ; Lambert L
J Pharm Pharmacol; 1988 Apr; 40(4):301-2. PubMed ID: 2900319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
